About
Solutions
Resources
Case Studies
Blog
Request a Demo

Evidence

The safety and efficacy of Glytec’s solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences around the globe. We invite you to explore them here.

Filter by Topic

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing

Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?

Subscribe to our blog

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Terms of Use
Legal Disclaimer
Privacy Policy
Contraindications, Warnings and Precautions

The eGlycemic Management System^® is a modularized solution for glycemic management across the care continuum that includes Glucommander^™. Glucommander^™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander^™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander^™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.